Kestra Advisory Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.44M Sell
11,757
-1,007
-8% -$331K 0.01% 991
2025
Q4
$4.47M Buy
12,764
+1,190
+10% +$402K 0.02% 799
2025
Q3
$3.74M Buy
11,574
+1,505
+15% +$468K 0.02% 828
2025
Q2
$3.92M Sell
10,069
-2,807
-22% -$1.13M 0.02% 752
2025
Q1
$5.6M Buy
12,876
+1,237
+11% +$497K 0.03% 536
2024
Q4
$4.29M Sell
11,639
-22,575
-66% -$9.45M 0.02% 634
2024
Q3
$17.8M Sell
34,214
-192
-0.6% -$103K 0.1% 222
2024
Q2
$18.6M Buy
34,406
+21,493
+166% +$11.4M 0.1% 210
2024
Q1
$6.7M Buy
12,913
+844
+7% +$420K 0.04% 428
2023
Q4
$5.69M Buy
12,069
+104
+0.9% +$48.1K 0.05% 412
2023
Q3
$5.21M Buy
11,965
+2,032
+20% +$922K 0.05% 372
2023
Q2
$4.41M Sell
9,933
-1,848
-16% -$853K 0.04% 409
2023
Q1
$5.42M Sell
11,781
-1,419
-11% -$675K 0.06% 330
2022
Q4
$6.77M Buy
13,200
+1,931
+17% +$980K 0.06% 333
2022
Q3
$5.12M Sell
11,269
-2,206
-16% -$1.06M 0.05% 368
2022
Q2
$6.5M Buy
13,475
+3,534
+36% +$1.75M 0.07% 300
2022
Q1
$4.88M Sell
9,941
-519
-5% -$237K 0.05% 376
2021
Q4
$4.85M Sell
10,460
-8,934
-46% -$3.76M 0.05% 379
2021
Q3
$7.23M Buy
19,394
+7,664
+65% +$2.91M 0.07% 298
2021
Q2
$4.48M Sell
11,730
-451
-4% -$172K 0.05% 384
2021
Q1
$4.37M Sell
12,181
-7,769
-39% -$2.5M 0.06% 363
2020
Q4
$6.26M Buy
19,950
+19,818
+15,014% +$6.08M 0.07% 287
2020
Q3
$2.31M Buy
+132
New +$35.5K 0.04% 392

Other funds holding ELV

Kestra Advisory Services's ELV Position: Q1 2026 in Review

Kestra Advisory Services reduced its Elevance Health (ELV) stake by 7.9% in Q1 2026, selling an estimated $331K and leaving 11,757 shares worth $3.44M. The position accounts for 0.01% of the portfolio, ranked #991.

Kestra Advisory Services first reported a position in ELV in Q3 2020 and has held it in 23 quarters since. The position peaked at $18.6M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Kestra Advisory Services held 11,757 shares of Elevance Health worth $3.44M as of Q1 2026.
  • Kestra Advisory Services sold 1,007 Elevance Health shares in Q1 2026, an estimated $331K.
  • Elevance Health made up 0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #991 holding.
  • Kestra Advisory Services first reported a position in Elevance Health in Q3 2020 and has held it in 23 quarters since.
  • Kestra Advisory Services's Elevance Health position peaked at $18.6M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.